What Drives Market Competition in Cancer Treatment?
Market competition in the field of cancer treatment is driven by several factors, including the complexity of the disease, the high costs associated with drug development, and the urgent need for innovative therapies. Pharmaceutical companies and biotech firms are constantly in a race to develop new and effective oncology drugs, often vying for the same market share. The pressure to innovate is intense, given the potential for significant financial returns and the life-saving impact of successful treatments.
